カテゴリー： GlobalInfoResearch, 世界

寄生虫症治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Parasitic Diseases Therapeutic Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9100234）・商品コード：GIR9100234
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年10月10日（※2024年版があります。お問い合わせください）
・ページ数：101
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、寄生虫症治療の世界市場について調べ、まとめました。種類別セグメントは、ペプチド医学、防虫剤、殺ダニ剤、その他等、用途別セグメントは、商業用、家庭用等に区分しました。寄生虫症治療の世界市場概観、企業動向、企業別寄生虫症治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・寄生虫症治療の市場概観
・寄生虫症治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・寄生虫症治療の企業別販売動向、市場シェア、市場集中度、競争動向
・寄生虫症治療の世界市場規模
・寄生虫症治療の北米市場分析（アメリカ、カナダ、メキシコ等）
・寄生虫症治療のアメリカ市場規模推移
・寄生虫症治療のカナダ市場規模推移
・寄生虫症治療のメキシコ市場規模推移
・寄生虫症治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・寄生虫症治療のドイツ市場規模推移
・寄生虫症治療のイギリス市場規模推移
・寄生虫症治療のロシア市場規模推移
・寄生虫症治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・寄生虫症治療の日本市場規模推移
・寄生虫症治療の中国市場規模推移
・寄生虫症治療の韓国市場規模推移
・寄生虫症治療のインド市場規模推移
・寄生虫症治療の東南アジア市場規模推移
・寄生虫症治療の南米市場分析（ブラジル、アルゼンチン等）
・寄生虫症治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・寄生虫症治療の種類別分析/販売量、売上、市場シェア（ペプチド医学、防虫剤、殺ダニ剤、その他）
・寄生虫症治療の用途別分析/市場規模（商業用、家庭用）
・寄生虫症治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・寄生虫症治療の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Parasitic diseases include amebiasis, trichomoniasis, trypanosomiasis, giardiasis, African sleeping sickness, leishmaniasis, and malaria.

Scope of the Report:
The global Parasitic Diseases Therapeutic market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Parasitic Diseases Therapeutic.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Parasitic Diseases Therapeutic market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Parasitic Diseases Therapeutic market by product type and applications/end industries.

Market Segment by Companies, this report covers
Bayer
F. Hoffmann-La Roche
GlaxoSmithKline
Pfizer
Sanaria

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Peptides Medicine
Insect Repellent
Acaricide
Other

Market Segment by Applications, can be divided into
Commercial
Household

【レポートの目次】

Table of Contents

1 Parasitic Diseases Therapeutic Market Overview
1.1 Product Overview and Scope of Parasitic Diseases Therapeutic
1.2 Classification of Parasitic Diseases Therapeutic by Types
1.2.1 Global Parasitic Diseases Therapeutic Revenue Comparison by Types (2019-2024)
1.2.2 Global Parasitic Diseases Therapeutic Revenue Market Share by Types in 2018
1.2.3 Peptides Medicine
1.2.4 Insect Repellent
1.2.5 Acaricide
1.2.6 Other
1.3 Global Parasitic Diseases Therapeutic Market by Application
1.3.1 Global Parasitic Diseases Therapeutic Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Commercial
1.3.3 Household
1.4 Global Parasitic Diseases Therapeutic Market by Regions
1.4.1 Global Parasitic Diseases Therapeutic Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Parasitic Diseases Therapeutic Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Parasitic Diseases Therapeutic Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Parasitic Diseases Therapeutic Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Parasitic Diseases Therapeutic Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Parasitic Diseases Therapeutic Status and Prospect (2014-2024)
1.5 Global Market Size of Parasitic Diseases Therapeutic (2014-2024)
2 Company Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Parasitic Diseases Therapeutic Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Parasitic Diseases Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.2 F. Hoffmann-La Roche
2.2.1 Business Overview
2.2.2 Parasitic Diseases Therapeutic Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 F. Hoffmann-La Roche Parasitic Diseases Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.3 GlaxoSmithKline
2.3.1 Business Overview
2.3.2 Parasitic Diseases Therapeutic Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GlaxoSmithKline Parasitic Diseases Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Parasitic Diseases Therapeutic Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Parasitic Diseases Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.5 Sanaria
2.5.1 Business Overview
2.5.2 Parasitic Diseases Therapeutic Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sanaria Parasitic Diseases Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
3 Global Parasitic Diseases Therapeutic Market Competition, by Players
3.1 Global Parasitic Diseases Therapeutic Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Parasitic Diseases Therapeutic Players Market Share
3.2.2 Top 10 Parasitic Diseases Therapeutic Players Market Share
3.3 Market Competition Trend
4 Global Parasitic Diseases Therapeutic Market Size by Regions
4.1 Global Parasitic Diseases Therapeutic Revenue and Market Share by Regions
4.2 North America Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
4.3 Europe Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
4.5 South America Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
5 North America Parasitic Diseases Therapeutic Revenue by Countries
5.1 North America Parasitic Diseases Therapeutic Revenue by Countries (2014-2019)
5.2 USA Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
5.3 Canada Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
5.4 Mexico Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
6 Europe Parasitic Diseases Therapeutic Revenue by Countries
6.1 Europe Parasitic Diseases Therapeutic Revenue by Countries (2014-2019)
6.2 Germany Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
6.3 UK Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
6.4 France Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
6.5 Russia Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
6.6 Italy Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Parasitic Diseases Therapeutic Revenue by Countries
7.1 Asia-Pacific Parasitic Diseases Therapeutic Revenue by Countries (2014-2019)
7.2 China Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
7.3 Japan Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
7.4 Korea Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
7.5 India Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
8 South America Parasitic Diseases Therapeutic Revenue by Countries
8.1 South America Parasitic Diseases Therapeutic Revenue by Countries (2014-2019)
8.2 Brazil Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
8.3 Argentina Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
8.4 Colombia Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Parasitic Diseases Therapeutic by Countries
9.1 Middle East and Africa Parasitic Diseases Therapeutic Revenue by Countries (2014-2019)
9.2 Saudi Arabia Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
9.3 UAE Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
9.4 Egypt Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
9.5 Nigeria Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
9.6 South Africa Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
10 Global Parasitic Diseases Therapeutic Market Segment by Type
10.1 Global Parasitic Diseases Therapeutic Revenue and Market Share by Type (2014-2019)
10.2 Global Parasitic Diseases Therapeutic Market Forecast by Type (2019-2024)
10.3 Peptides Medicine Revenue Growth Rate (2014-2024)
10.4 Insect Repellent Revenue Growth Rate (2014-2024)
10.5 Acaricide Revenue Growth Rate (2014-2024)
10.6 Other Revenue Growth Rate (2014-2024)
11 Global Parasitic Diseases Therapeutic Market Segment by Application
11.1 Global Parasitic Diseases Therapeutic Revenue Market Share by Application (2014-2019)
11.2 Parasitic Diseases Therapeutic Market Forecast by Application (2019-2024)
11.3 Commercial Revenue Growth (2014-2019)
11.4 Household Revenue Growth (2014-2019)
12 Global Parasitic Diseases Therapeutic Market Size Forecast (2019-2024)
12.1 Global Parasitic Diseases Therapeutic Market Size Forecast (2019-2024)
12.2 Global Parasitic Diseases Therapeutic Market Forecast by Regions (2019-2024)
12.3 North America Parasitic Diseases Therapeutic Revenue Market Forecast (2019-2024)
12.4 Europe Parasitic Diseases Therapeutic Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Parasitic Diseases Therapeutic Revenue Market Forecast (2019-2024)
12.6 South America Parasitic Diseases Therapeutic Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Parasitic Diseases Therapeutic Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Parasitic Diseases Therapeutic Picture
Table Product Specifications of Parasitic Diseases Therapeutic
Table Global Parasitic Diseases Therapeutic and Revenue (Million USD) Market Split by Product Type
Figure Global Parasitic Diseases Therapeutic Revenue Market Share by Types in 2018
Figure Peptides Medicine Picture
Figure Insect Repellent Picture
Figure Acaricide Picture
Figure Other Picture
Table Global Parasitic Diseases Therapeutic Revenue (Million USD) by Application (2014-2024)
Figure Parasitic Diseases Therapeutic Revenue Market Share by Applications in 2018
Figure Commercial Picture
Figure Household Picture
Table Global Market Parasitic Diseases Therapeutic Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Parasitic Diseases Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Parasitic Diseases Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Parasitic Diseases Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Parasitic Diseases Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Parasitic Diseases Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Parasitic Diseases Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Parasitic Diseases Therapeutic Type and Applications
Table Bayer Parasitic Diseases Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche Parasitic Diseases Therapeutic Type and Applications
Table F. Hoffmann-La Roche Parasitic Diseases Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Parasitic Diseases Therapeutic Type and Applications
Table GlaxoSmithKline Parasitic Diseases Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Parasitic Diseases Therapeutic Type and Applications
Table Pfizer Parasitic Diseases Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Sanaria Basic Information, Manufacturing Base and Competitors
Table Sanaria Parasitic Diseases Therapeutic Type and Applications
Table Sanaria Parasitic Diseases Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Global Parasitic Diseases Therapeutic Revenue (Million USD) by Players (2014-2019)
Table Global Parasitic Diseases Therapeutic Revenue Share by Players (2014-2019)
Figure Global Parasitic Diseases Therapeutic Revenue Share by Players in 2017
Figure Global Parasitic Diseases Therapeutic Revenue Share by Players in 2018
Figure Global Top 5 Players Parasitic Diseases Therapeutic Revenue Market Share in 2018
Figure Global Top 10 Players Parasitic Diseases Therapeutic Revenue Market Share in 2018
Figure Global Parasitic Diseases Therapeutic Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Parasitic Diseases Therapeutic Revenue (Million USD) by Regions (2014-2019)
Table Global Parasitic Diseases Therapeutic Revenue Market Share by Regions (2014-2019)
Figure Global Parasitic Diseases Therapeutic Revenue Market Share by Regions (2014-2019)
Figure Global Parasitic Diseases Therapeutic Revenue Market Share by Regions in 2018
Figure North America Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
Figure Europe Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
Figure South America Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
Table North America Parasitic Diseases Therapeutic Revenue by Countries (2014-2019)
Table North America Parasitic Diseases Therapeutic Revenue Market Share by Countries (2014-2019)
Figure North America Parasitic Diseases Therapeutic Revenue Market Share by Countries (2014-2019)
Figure North America Parasitic Diseases Therapeutic Revenue Market Share by Countries in 2018
Figure USA Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
Figure Canada Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
Figure Mexico Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
Table Europe Parasitic Diseases Therapeutic Revenue (Million USD) by Countries (2014-2019)
Figure Europe Parasitic Diseases Therapeutic Revenue Market Share by Countries (2014-2019)
Figure Europe Parasitic Diseases Therapeutic Revenue Market Share by Countries in 2018
Figure Germany Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
Figure UK Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
Figure France Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
Figure Russia Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
Figure Italy Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Parasitic Diseases Therapeutic Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Parasitic Diseases Therapeutic Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Parasitic Diseases Therapeutic Revenue Market Share by Countries in 2018
Figure China Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
Figure Japan Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
Figure Korea Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
Figure India Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
Table South America Parasitic Diseases Therapeutic Revenue by Countries (2014-2019)
Table South America Parasitic Diseases Therapeutic Revenue Market Share by Countries (2014-2019)
Figure South America Parasitic Diseases Therapeutic Revenue Market Share by Countries (2014-2019)
Figure South America Parasitic Diseases Therapeutic Revenue Market Share by Countries in 2018
Figure Brazil Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
Figure Argentina Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
Figure Colombia Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Parasitic Diseases Therapeutic Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Parasitic Diseases Therapeutic Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Parasitic Diseases Therapeutic Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Parasitic Diseases Therapeutic Revenue Market Share by Countries in 2018
Figure Saudi Arabia Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
Figure UAE Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
Figure Egypt Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
Figure Nigeria Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
Figure South Africa Parasitic Diseases Therapeutic Revenue and Growth Rate (2014-2019)
Table Global Parasitic Diseases Therapeutic Revenue (Million USD) by Type (2014-2019)
Table Global Parasitic Diseases Therapeutic Revenue Share by Type (2014-2019)
Figure Global Parasitic Diseases Therapeutic Revenue Share by Type (2014-2019)
Figure Global Parasitic Diseases Therapeutic Revenue Share by Type in 2018
Table Global Parasitic Diseases Therapeutic Revenue Forecast by Type (2019-2024)
Figure Global Parasitic Diseases Therapeutic Market Share Forecast by Type (2019-2024)
Figure Global Peptides Medicine Revenue Growth Rate (2014-2019)
Figure Global Insect Repellent Revenue Growth Rate (2014-2019)
Figure Global Acaricide Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global Parasitic Diseases Therapeutic Revenue by Application (2014-2019)
Table Global Parasitic Diseases Therapeutic Revenue Share by Application (2014-2019)
Figure Global Parasitic Diseases Therapeutic Revenue Share by Application (2014-2019)
Figure Global Parasitic Diseases Therapeutic Revenue Share by Application in 2018
Table Global Parasitic Diseases Therapeutic Revenue Forecast by Application (2019-2024)
Figure Global Parasitic Diseases Therapeutic Market Share Forecast by Application (2019-2024)
Figure Global Commercial Revenue Growth Rate (2014-2019)
Figure Global Household Revenue Growth Rate (2014-2019)
Figure Global Parasitic Diseases Therapeutic Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Parasitic Diseases Therapeutic Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Parasitic Diseases Therapeutic Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Parasitic Diseases Therapeutic Revenue Market Forecast (2019-2024)
Figure Europe Parasitic Diseases Therapeutic Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Parasitic Diseases Therapeutic Revenue Market Forecast (2019-2024)
Figure South America Parasitic Diseases Therapeutic Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Parasitic Diseases Therapeutic Revenue Market Forecast (2019-2024)


【掲載企業】

Bayer、F. Hoffmann-La Roche、GlaxoSmithKline、Pfizer、Sanaria

★調査レポート[寄生虫症治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9100234)販売に関する免責事項を必ずご確認ください。
★調査レポート[寄生虫症治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 治療用酵素の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103622 / GlobalInfoResearch / 2019年9月27日 / 本調査レポートは、治療用酵素の世界市場について調べ、まとめました。種類別セグメントは、注射、経口、局所等、用途別セグメントは、ゴーシェ病、MPS疾患、胃腸疾患、その他等に区分しました。治療用酵素の世界市場概観、メーカー動向、メーカー別治療用酵素シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・治療用酵素の市場概観 ・治療用酵素の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・治療用酵素の企業別販売動向、市場シェア、市場集中度、競争動向 ・治療用酵素の世界市場規模 ・治療用酵素の北米市場分析（アメリカ、カナダ、メキシコ等） ・治療用酵素のアメリカ市場規模推移 ・治療用酵素のカナダ市場規模推移 ・治療用酵素のメキシコ市場規模推移 ・治療用酵素のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Description Scope of the Report: The worldwide market for Therapeutic Enzymes is expected to grow at a CAGR of roughly 11.5% over the next five years, will reach 12640 million US$ in 2024, from 8165.5 million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Therapeutic Enzymes in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Sanofi Johnson & Johnson Shire BioMarin Allergan AbbVie Pfizer Horizon...
  • 皮膚科用診断および治療装置の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100420 / GlobalInfoResearch / 2019年10月11日 / 本調査レポートは、皮膚科用診断および治療装置の世界市場について調べ、まとめました。種類別セグメントは、皮膚科診断装置、皮膚科治療装置等、用途別セグメントは、病院、診療所、その他等に区分しました。皮膚科用診断および治療装置の世界市場概観、メーカー動向、メーカー別皮膚科用診断および治療装置シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・皮膚科用診断および治療装置の市場概観 ・皮膚科用診断および治療装置の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・皮膚科用診断および治療装置の企業別販売動向、市場シェア、市場集中度、競争動向 ・皮膚科用診断および治療装置の世界市場規模 ・皮膚科用診断および治療装置の北米市場分析（アメリカ、カナダ、メキシコ等） ・皮膚科用診断および治療装置のアメリカ市場規模推移 ・皮膚科用診断および治療装置のカナダ市場規模推移 ・皮膚科用診断および治療装置のメキシコ市場規模推移 ・皮膚科用診断および治療装置のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The worldwide market for Dermatology Diagnostic and Therapeutic Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Dermatology Diagnostic and Therapeutic Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Stiefel LEO Pharma Dino-Lite...

    • ◆H&Iグローバルリサーチのお客様（例）◆